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Editorial 
Autophagy in cellular transformation, survival and communication with the tumor 
microenvironment 
 
Abstract 
Autophagy describes several metabolic pathways, by which cytoplasmic constituents are 
imported into lysosomes for degradation. These pathways and in particular macroautophagy 
play an important role during oncogenesis by apparently inhibiting cellular transformation initially, 
but then ensuring tumor cell survival in established cancers. Furthermore, the conditioning of the 
tumor microenvironment, including the cross-talk with the immune system, is influenced by 
autophagy. These multiple facets of autophagy regulation in tumors will be discussed in the 
series of review articles of this issue of Seminars in Cancer Biology. A comprehensive 
understanding of this pathway in oncology is needed to efficiently apply autophagy regulating 
tumor therapies, which are already in use.  
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Autophagy comprises at least three metabolic pathways that deliver cytoplasmic constituents for 
lysosomal degradation [1, 2]. During microautophagy substrates invaginate either into the 
lysosmal or late endosomal membrane for degradation by lyosomal hydrolases. Chaperone-
mediated autophagy translocates proteins in a signal peptide dependent manner across the 
lysosomal membrane. Finally, macroautophagy engulfs cytoplasmic content, including damaged 
organelles, protein aggregates and cytosolic pathogens, with a double-membrane, which upon 
closure forms an autophagosome that then fuses with lysosomes or late endosomes. 
Macroautophagy is the most intensively studied mechanisms of the three pathways and its role 
for cancer biology will be primarily discussed in the reviews of this issue of Seminars in Cancer 
Biology.  
 Macroautophagy requires more than 30 autophagy-related proteins to initiate 
autophagosome formation at a membrane, to complete autophagosome formation around its 
cargo, and to regulate fusion of autophagosomes with other membrane compartments. Three 
reviews will address these molecular mechanisms for macroautophagy in cancer cells. Sharon 
Tooze and colleagues will discuss the regulation of the ULK1/Atg1 and Beclin1/Atg6-PI3KC3 
complexes in autophagosome initiation [3]. These two complexes are essential for 
macroautophagy and targeted in tumor cells to manipulate the pathway. Furthermore, Guido 
Kroemer and coworkers will out-line the influence of stress-induced transcription factors on 
macroautophagy in cancer cells [4]. This regulation of macroautophagy is especially important 
during up-regulation of macroautophagy in established tumors. Finally, Michael Overholtzer and 
his co-author will focus on an alternative use of the molecular core machinery of 
macroautophagy in regulating phagocytosis [5]. This alternative use of macroautophagy 
components has to be kept in mind, when analyzing this pathway and exploring its therapeutic 
regulation. 
 A second set of reviews will explore the dichotomy of macroautophagy regulation in 
tumors. Curiously, a picture has emerged in recent years that macroautophagy blocks 
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transformation initially, and therefore genetic loss of macroautophagy components can be 
observed in some tumors, while the nutrient starvation conditions in established tumors, require 
then epigenetic macroautophagy up-regulation for the survival of the tumor. Along these lines, 
Mauro Piacentini and colleagues will discuss such genetic alterations of macroautophagy and 
their epigenetic compensation in melanoma as a tumor example [6]. Kevin Ryan and co-worker 
will out-line, how these macroautophagy regulations intersects with cell death [7]. Finally, Hans-
Uwe Simon and his co-authors will explore, how tumor therapies already manipulate 
macroautophagy [8]. These reviews focus on the cell intrinsic requirements of tumor cells to 
regulate macroautophagy during tumor growth. 
 The final set of reviews then characterizes, how the very same modulations of 
macroautophagy also influence the communication of tumor cells with their microenvironment.  
Patrice Codogno and colleagues out-line how the changes in nutritional requirements during 
tumorigenesis can also be overcome by inducing macroautophagy in the tumor 
microenvironment [9]. In this discussion, genetic lesions that down-regulate macroautophagy 
initially for transformation are juxtaposed to mechanisms that up-regulate nutrient production via 
macroautophagy up-regulation in accessory cells in tumors. Michael Lotze and coworkers then 
describe how macroautophagy in tumor cells influences the inflammatory environment of the 
tumor (Lotze et al., Semin Cancer Biol 2013). These mechanisms allow immune activation and 
visualization of tumors to the immune system. We complete this set of reviews by discussing, 
how macroautophagy then influences the presentation of tumor antigens for tumor rejection or 
tolerance induction [10]. In this respect the catabolic products of this pathway are reused by the 
immune system to monitor the health of the tumor cell proteome. Thus, macroautophagy does 
not only regulate the metabolism of tumor cells directly, but also via manipulating the cancer 
microenvironment.  
 These many facets of the role of macroautophagy in cancer biology make it an attractive, 
but also complicated pathway to manipulate for the benefit of patients. In part the timing of 
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therapeutic intervention by macroautophagy regulation will be decisive for the outcome. 
Nevertheless, with new reagents that can therapeutically regulate macroautophagy [11, 12] for 
clinical benefit in infectious diseases, neurodegeneration and tumors [13], more specific and 
finely tuned interventions can be performed. The knowledge on the regulation of 
macroautophagy during tumorigenesis that has been gathered during the last years, will guide 
these therapeutic approaches.  
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